Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new children’s orthopaedic hospital in Bulawayo that will treat children across Zimbabwe who are living with musculoskeletal impairments has opened today.

CURE International Hospital © CURE Children’s Hospital of Zimbabwe, photo courtesy of CURE International

The CURE Children’s Hospital of Zimbabwe was formally opened by the President of Zimbabwe, Emmerson Mnangagwa today. The new hospital based in Bulawayo will treat children across Zimbabwe who are living with disabilities such as neglected clubfoot, bowed legs, and knock knees, helping them return to normal life. The existing hospital buildings in central Bulawayo and hospital site provided by United Bulawayo Hospitals have been renovated and a new theatre block built.

Professor Chris Lavy, honorary consultant orthopaedic and spine surgeon and Professor of Orthopaedic and Tropical Surgery at NDORMS, is a trustee and he has been involved in the project from the beginning. He has worked with funders and local health professionals and stakeholders in developing an innovative public-private health partnership. He says: “I am very delighted that the hospital is open and available to children with surgically treatable orthopaedic conditions, enabling them to run and walk normally. We are very grateful to all the individuals and partners along the way who have supported the dream of this hospital. We hope this teaching hospital will be a resource to the health community.”

The medical director at CURE Children’s Hospital of Zimbabwe, Dr Collen Msasanure, hosted a regional hip and knee replacement training course in Bulawayo a few years ago with visiting Oxford and local faculty. Prof Lavy says, “We look forward to working together with Dr Msasanure, local surgeons in Zimbabwe, and CURE Zimbabwe on future surgical training opportunities.” This builds on NDORMS’ strong orthopaedic surgery research, training and capacity-building links with Southern Africa since 2012 through the UK DFID Health Partnership Scheme link between University of Oxford and the College of Surgeons of East, Central and Southern Africa (COSECSA Oxford Orthopaedic Link). Led by Prof Chris Lavy and Professor Godfrey Muguti (President of COSECSA), this multi-country programme has included running five training courses (paediatric orthopaedics, musculoskeletal tumours, joint replacement) for orthopaedic surgical registrars in Malawi, Zambia and Zimbabwe led by visiting teams of surgeons from the Nuffield Orthopaedic Centre; establishing training fellowships for local surgical registrars at CURE International orthopaedic children’s teaching hospitals in the region; and epidemiological research into the burden of children’s musculoskeletal impairment.

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.